| CERIBELL INC. |
| USA |
| US15678C1027 / A40N76 |
| W3H (Frankfurt) / CBLL (NASDAQ) |
| FRA:W3H, ETR:W3H, W3H:GR, NASDAQ:CBLL |
| - |
| - |
|
Ceribell Inc. is a medical technology company focused on acute-care neurodiagnostics. Ceribell develops the Ceribell System, a point-of-care EEG platform designed to help clinicians detect and manage serious neurological conditions at the bedside. It..
>Volltext.. |
| 965.52 Mio. EUR |
| 869.99 Mio. EUR |
| 90.74 Mio. EUR |
| -61.23 Mio. EUR |
| -58.73 Mio. EUR |
| -1.57 EUR |
| 19.5 Mio. EUR |
| 29.07 Mio. EUR |
| -48.22 Mio. EUR |
| 7.52 |
| 31.7% |
| -33.56% |
| - |
| - |
| - |
| - |
| 04.11.26 |
|